The Truth About Ivermectin Side Effects: Myths vs Facts
Updated: Sep 30
Written by Elizabeth Chernoby in TheSkyMeds Editorial Standards
Medically reviewed by Jonathan Reed, Medical Content Reviewer Dec 8 2025
Discussions about ivermectin side effects often swing between two extremes: claims that the medicine is completely harmless and claims that taking ivermectin is inherently dangerous. Neither accurately reflects the evidence. Ivermectin is an established antiparasitic medicine, and approved human doses have generally been well tolerated when used appropriately, but it can cause gastrointestinal, neurological, skin, and other adverse effects. Rare serious reactions, including severe neurological effects and serious skin reactions, have also been reported after marketing. The illness being treated matters too, because some reactions after ivermectin treatment can result partly from the body's inflammatory response to dying parasites rather than direct drug toxicity alone. Understanding the difference between expected side effects, disease-related treatment reactions, dangerous overdose, and inappropriate veterinary-product use provides a much more accurate picture of ivermectin safety.
What Is Ivermectin, and When Is It Used?
Ivermectin is an antiparasitic medicine with decades of human use. In the United States, oral ivermectin tablets are indicated for intestinal strongyloidiasis and onchocerciasis, two infections caused by parasites.
CDC also identifies ivermectin as first-line treatment for acute and chronic strongyloidiasis and includes oral ivermectin among recommended treatments for scabies in appropriate circumstances.
That history is important when assessing safety: ivermectin is a legitimate human medicine when used for appropriate indications and in an appropriate formulation.
The official U.S. ivermectin prescribing information provides the clearest distinction between expected adverse reactions, reactions related to particular parasitic infections, and uncommon serious post-marketing events.
Does being an approved medicine mean ivermectin has no risks?
No medicine is risk-free.
Regulatory approval means a drug's benefits and risks have been evaluated for specific indications and conditions of use. It does not mean that every dose, duration, formulation, or unapproved use has the same benefit-risk balance.
Safety therefore depends partly on why ivermectin is being taken, how much is taken, the formulation, other medicines, underlying health conditions, and—in some parasitic diseases—the parasite burden itself.
Are human and veterinary ivermectin the same thing?
They can contain the same active drug, but veterinary formulations are not interchangeable with human medicines.
Animal products may have different concentrations, inactive ingredients, formulations, and dosing instructions designed for particular species and body weights.
Human exposure to excessive amounts of veterinary ivermectin has been associated with significant toxicity. The existence of veterinary ivermectin therefore should never be interpreted as a convenient substitute for an appropriately prescribed or labeled human formulation.
Ivermectin safety cannot be reduced to “safe” or “dangerous.” At established human doses for appropriate parasitic infections, adverse effects are often mild and transient. Excessive exposure, inappropriate formulations, susceptible patients, and rare serious reactions create a very different risk profile.
What Are the Common Side Effects of Ivermectin?
Commonly reported effects with oral ivermectin include dizziness, nausea, diarrhea, itching, and other relatively mild symptoms, although frequency varies by the infection being treated.
In U.S. prescribing information, four strongyloidiasis studies involving 109 patients receiving one or two doses around 170–200 micrograms/kg reported drug-related dizziness in 2.8%, itching in 2.8%, diarrhea in 1.8%, and nausea in 1.8%. Fatigue, abdominal pain, vomiting, sleepiness, vertigo, tremor, rash, and hives occurred less frequently.
These figures come from relatively small historical clinical studies and should not be interpreted as precise rates for every population or use.
Can ivermectin cause dizziness or sleepiness?
Yes.
Dizziness was among the more frequently reported possibly or probably drug-related adverse effects in the strongyloidiasis trials described in U.S. labeling. Sleepiness, vertigo, and tremor were also reported, although less frequently.
Anyone who becomes dizzy or unusually drowsy should avoid activities where impaired alertness could cause harm and seek medical advice if symptoms are severe or persistent.
Can ivermectin cause nausea or diarrhea?
Yes. Gastrointestinal effects can occur.
Nausea, diarrhea, vomiting, abdominal discomfort, constipation, and reduced appetite have been reported during oral ivermectin treatment.
However, gastrointestinal symptoms can also be caused by the parasitic disease itself. Strongyloidiasis, for example, can produce abdominal pain, diarrhea, constipation, bloating, and other digestive symptoms.
This can sometimes make it difficult to determine whether a symptom comes from the medicine, the infection, or both.
Effect | What the evidence shows | Practical context |
Dizziness | Reported with oral ivermectin | Usually mild, but severe neurological symptoms are different |
Nausea | Recognized adverse effect | Can also occur with illness or other medicines |
Diarrhea | Recognized adverse effect | Strongyloidiasis itself can cause diarrhea |
Fatigue | Reported in clinical trials | Nonspecific symptom with many possible causes |
Itching/rash | Can occur after treatment | May be drug-related or, in some parasitic infections, related to dying parasites |
Sleepiness | Reported but less common in strongyloidiasis trials | Significant altered consciousness requires urgent assessment |
Low blood pressure | Reported post-marketing; disease-related reactions can also contribute | Fainting or severe weakness deserves medical attention |
Serious neurological effects | Rare but reported post-marketing | Confusion, seizures, stupor or coma require urgent care |
Why Can Ivermectin Reactions Differ Between Parasitic Infections?
Some symptoms occurring after ivermectin are not straightforward drug side effects. In onchocerciasis, treatment kills microfilariae—the microscopic larval stage of the parasite—which can trigger inflammatory reactions known as Mazzotti reactions.
These reactions can include itching, rash, swelling, fever, joint symptoms, and tender or enlarged lymph nodes. U.S. labeling states that these reactions are probably caused by allergic and inflammatory responses to dying microfilariae.
That distinction explains why adverse-event patterns from one parasitic disease cannot simply be applied to another.
Is every rash an ivermectin allergy?
No.
Itching, rash, and hives can be drug-related, but certain parasitic infections can produce inflammatory skin reactions when parasites die after treatment.
A mild temporary rash and a severe drug reaction are also very different clinical situations.
Blistering or peeling skin, extensive rash, sores involving the mouth or eyes, facial swelling, or difficulty breathing requires urgent medical assessment because rare serious hypersensitivity and skin reactions have been reported with ivermectin.
Can treating onchocerciasis affect the eyes?
Eye-related changes have been observed after ivermectin treatment for onchocerciasis, but interpretation requires care because the infection itself can cause eye disease.
U.S. labeling reports several ophthalmological changes after treatment, while noting that many subsequently returned toward baseline or improved.
These disease-specific observations should not be presented as though every person taking ivermectin has the same eye risk.
Can Ivermectin Cause Serious Side Effects?
Yes, although serious reactions are much less common than mild effects at standard therapeutic exposure.
Post-marketing reports in U.S. labeling include low blood pressure, seizures, hepatitis, elevated liver enzymes, serious skin reactions such as Stevens-Johnson syndrome and toxic epidermal necrolysis, and neurotoxicity involving confusion, disorientation, altered consciousness, stupor, coma, and death.
Post-marketing reports have an important limitation: they can identify possible safety signals but usually cannot provide a reliable incidence because reporting is voluntary and causation may be uncertain.
Is severe ivermectin neurotoxicity real?
Yes, but describing it requires context.
A 2026 toxicology review concluded that ivermectin generally has a favorable safety profile under controlled therapeutic conditions while documenting rare severe neurological events in real-world reports, particularly with excessive exposure and in susceptible individuals.
Current U.S. labeling likewise warns that neurotoxicity—including altered consciousness, confusion, disorientation and death—has been reported.
This means “ivermectin always causes neurological damage” is false, but “serious neurological toxicity cannot happen” is also false.
Can ivermectin affect the liver?
Liver-related abnormalities are possible.
Post-marketing labeling includes hepatitis and elevations in liver enzymes and bilirubin. In historical strongyloidiasis trials, elevations in ALT or AST occurred in a small proportion of participants, although the label reports those laboratory findings regardless of whether investigators considered ivermectin responsible.
People with significant liver disease or abnormal liver symptoms should therefore discuss treatment and monitoring with a healthcare professional.
Ivermectin Myths vs Facts: What Does the Evidence Actually Say?
The most accurate way to discuss ivermectin is to avoid both exaggerating and minimizing its risks.
A medicine can have a generally favorable safety record for established indications while still producing adverse effects and occasionally serious toxicity.
It is equally important not to use safety data from controlled therapeutic use to justify unlimited dosing or unrelated indications.
Myth: “Ivermectin is completely harmless.”
Fact: Ivermectin has recognized adverse effects.
Clinical trials and post-marketing surveillance document gastrointestinal, neurological, skin, cardiovascular, hepatic, and other reactions.
Most adverse effects at established therapeutic exposure are not severe, but rare serious events have been reported. Calling the medicine completely harmless therefore goes beyond the evidence.
Myth: “Ivermectin is inherently poisonous to humans.”
Fact: Human ivermectin is an established antiparasitic medicine.
CDC identifies ivermectin as first-line therapy for strongyloidiasis, and U.S. drug labeling includes established human indications for strongyloidiasis and onchocerciasis.
The meaningful safety question is not whether ivermectin is “poison.” It is whether a human formulation is being used for an appropriate indication, at an evidence-based dose, in a suitable patient.
Myth: “If higher doses were tolerated in studies, taking extra ivermectin is safe.”
Fact: That conclusion is not supported.
A systematic review examining higher-dose ivermectin found broadly similar adverse-event patterns in the limited trials available, but the authors explicitly concluded that there were insufficient data to recommend higher-than-approved doses.
Controlled research also involves screening, defined formulations, measured doses, and monitoring—conditions that differ greatly from unsupervised high-dose use.
Myth: “Veterinary ivermectin is just cheaper human ivermectin.”
Fact: Veterinary formulations should not be treated as substitutes for human medicine.
FDA documentation describes significant adverse effects following human exposure to veterinary ivermectin formulations, including dizziness, vomiting, diarrhea, seizures, problems with coordination, breathing difficulty, and other toxic effects.
Concentration and formulation can also differ substantially.
Who Needs Extra Caution With Ivermectin?
Ivermectin should be considered in the context of the individual rather than treated as a universally interchangeable medicine.
CDC lists relative contraindications or special considerations for ivermectin treatment of strongyloidiasis that include confirmed or suspected Loa loa infection, pregnancy or lactation, and body weight below 15 kg.
The safety of multiple doses in severe liver disease also has limitations in the available evidence.
Why does Loa loa infection matter?
People with heavy Loa loa microfilarial infection can be at risk of serious neurological complications when treated with microfilaricidal medicines.
U.S. ivermectin labeling specifically warns that people heavily infected with Loa loa may develop serious or even fatal encephalopathy following treatment with microfilaricidal drugs.
Travel and residence history can therefore matter when ivermectin is being considered for certain parasitic infections.
What about pregnancy and breastfeeding?
These situations require individualized medical assessment rather than self-treatment.
CDC notes that ivermectin should be used during pregnancy only when the potential benefit justifies potential fetal risk. It also states that ivermectin is excreted in low concentrations in human milk and that use while breastfeeding requires weighing treatment benefits against potential risk.
Recommendations can also differ according to the infection being treated.
Can ivermectin interact with other medicines?
Yes, clinically relevant interactions and combined effects are possible.
CDC's scabies guidance specifically advises considering ivermectin drug interactions when selecting treatment.
Rather than relying on a short generic interaction list, people taking prescription medicines should have their complete medication and supplement list reviewed by a pharmacist or clinician when ivermectin treatment is being considered.
Do | Don't |
Use a human formulation for an established or professionally assessed indication | Do not substitute veterinary ivermectin |
Follow the dose prescribed or specified for the condition | Do not increase the dose because you assume more will work better |
Tell your clinician about other medicines and supplements | Do not assume antiparasitic medicines are interaction-free |
Mention relevant travel or residence history | Do not ignore potential exposure to parasites such as Loa loa |
Report significant neurological, allergic, or liver-related symptoms | Do not dismiss confusion, seizures, severe rash, or loss of consciousness |
Discuss pregnancy, breastfeeding, liver disease, and treatment of young children | Do not extrapolate adult dosing to children |
Use evidence for the disease actually being treated | Do not transfer a dose from one condition to an unrelated illness |
When Do Ivermectin Side Effects Need Medical Attention?
Mild nausea, diarrhea, dizziness, or itching may resolve without serious consequences, but severe or rapidly worsening symptoms require a different response.
Seek urgent medical attention for confusion, marked disorientation, seizures, extreme drowsiness, inability to remain conscious, severe difficulty walking, fainting, serious breathing difficulty, or coma. These can be features of severe neurological or systemic toxicity.
Severe blistering or peeling rash, extensive skin pain, mouth or eye sores, facial or throat swelling, or difficulty breathing also requires urgent evaluation because serious skin and hypersensitivity reactions have been reported.
Possible liver warning signs—including jaundice, dark urine, unusually pale stools, or significant persistent upper abdominal symptoms—also deserve medical assessment.
Anyone who has accidentally taken a large or uncertain amount of ivermectin, particularly a veterinary formulation, should seek urgent poison-control or medical guidance rather than waiting for symptoms to appear.
Conclusion
The evidence on ivermectin side effects is more nuanced than many online discussions suggest. Human ivermectin has established antiparasitic uses and is generally well tolerated when appropriately used, but dizziness, nausea, diarrhea, itching, and other adverse effects can occur. Rare serious neurological, liver, skin, and other reactions have also been reported.
Safety data from standard treatment should not be used to justify excessive doses, veterinary formulations, or unsupported uses. If ivermectin is medically appropriate, use the correct human formulation and indication-specific regimen, and discuss important health conditions and interacting medicines with a healthcare professional.
Frequently Asked Questions
1 . What are the most common side effects of ivermectin?
Oral ivermectin can cause dizziness, nausea, diarrhea, itching, fatigue, abdominal discomfort, rash, and other usually mild effects. Frequency varies according to the infection and population being treated. Some symptoms following parasite treatment can also result from inflammatory responses to dying organisms rather than direct drug toxicity alone.
2 . Can ivermectin cause neurological damage?
Serious neurotoxicity is uncommon but has been reported. Current U.S. labeling includes altered consciousness, confusion, disorientation, stupor, coma, and death among post-marketing neurological reports. Controlled therapeutic use is generally well tolerated, so these rare events should not be presented as inevitable effects of taking appropriately prescribed ivermectin.
3 . Is ivermectin safe for humans?
Ivermectin is an established human antiparasitic medicine and is generally well tolerated when appropriately used for supported indications. That does not make it risk-free. Safety depends on the indication, formulation, dose, individual health factors, parasite involved, other medicines, and whether treatment is being appropriately monitored.
4 . Can you overdose on ivermectin?
Yes. Excessive ivermectin exposure can cause significant toxicity, including vomiting, dizziness, coordination problems, low blood pressure, seizures, breathing problems, and neurological impairment. An overdose or uncertain exposure requires medical or poison-control advice. High-dose research should never be interpreted as permission to experiment with unsupervised doses.
5 . Is veterinary ivermectin safe for people?
Veterinary ivermectin should not be substituted for human medicine. Animal formulations may have different concentrations and formulations, creating a substantial dosing risk. Human intoxication after exposure to veterinary ivermectin has produced neurological, gastrointestinal, cardiovascular, and other adverse effects. Use an appropriate human formulation when ivermectin is medically indicated.
6 . Can ivermectin cause liver problems?
Liver-related reactions have been reported, including hepatitis and increased liver enzymes and bilirubin in post-marketing surveillance. Such events appear much less common than mild gastrointestinal or neurological effects. People with significant liver disease or symptoms suggesting liver injury should obtain professional advice rather than continuing or repeating ivermectin independently.
Comments